1,1'-(2-Methylpiperazine-1,4-diyl)bis(propan-2-ol)

Catalog No. :
ACHUDX560
CAS No. :
94-72-4
Molecular Formula :
C11H24N2O2
Molecular Weight :
216.32

IUPAC Name:1,1'-(2-methylpiperazine-1,4-diyl)bis(propan-2-ol)

1,1'-(2-Methylpiperazine-1,4-diyl)bis(propan-2-ol) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$67.00Login to see priceInquiryInquiry
5g95%$126.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,1'-(2-Methylpiperazine-1,4-diyl)bis(propan-2-ol)
IUPAC Name1,1'-(2-methylpiperazine-1,4-diyl)bis(propan-2-ol)
MDL No.MFCD00023300
Molecular FormulaC11H24N2O2
Molecular Weight216.32
SMILESCC1N(CC(O)C)CCN(CC(O)C)C1
InChI KeyGPXSTLAIBOEFST-UHFFFAOYSA-N
Synonym3,3'-(2-methylpiperazine-1,4-diyl)dipropan-2-ol;α,α',2-Trimethyl-1,4-piperazinediethanol;Einecs 202-359-0;Nsc 59817;1-[4-(2-hydroxypropyl)-3-methylpiperazin-1-yl]propan-2-ol;1,4-Piperazinediethanol, α1,α4,2-trimethyl-;1-[4-(2-hydroxypropyl)-2-methylpiperazin-1-yl]propan-2-ol
CAS No.94-72-4

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P310-P302+P352-P304+P340-P305+P351+P338-P312-P321-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACHUDX560 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHUDX560 route product structure diagram
    ACHUDX56094-72-4
Inquiry

2. ACHUDX560 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHUDX560 route product structure diagram
    ACHUDX56094-72-4
Inquiry

Comments (0)